title: Cost minimisation of RSV prevention with palivizumab.
authors.forename: S
authors.initials: S
authors.lastname: Wills
authors.forename: J H
authors.initials: JH
authors.lastname: Simpson
authors.forename: J
authors.initials: J
authors.lastname: Coutts
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D002648:Child; D017046:Cost Savings; D006801:Humans; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000191:economics
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab